Psychedelic-Assisted Therapy for Trauma and Autoimmunity

Mark Hyman and Sarah Gottfried claim that psychedelic-assisted therapies, particularly MDMA and ketamine, show promise in treating trauma associated with autoimmune diseases, suggesting these therapies address both psychological and biological aspects of trauma.

AI-generated summary — may contain errors. How it works